Stress-induced hyperglycaemia is a significant problem in critically ill patients, including those with surgical or traumatic injury in the intensive care unit (ICU). The severity of hyperglycemia and insulin resistance reflect the risk of death. A recent, large, prospective, randomized, controlled study showed that maintaining normoglycemia with intensive insulin therapy improves survival and reduces morbidity in a surgical ICU population. Recent data from observational studies has confirmed the clinical benefits of glycaemic control in both surgical and mixed surgical/medical ICU conditions. Titrating insulin to normoglycaemia appears to be crucial in order to achieve most clinical benefits. Prevention of glucose toxicity protects the endothelium as well as ultrastructure and function of hepatocyte mitochondria. Other metabolic and non-metabolic effects of the insulin administered contribute to the clinical benefits, including a partial correction of the deranged serum lipid profile, prevention of excessive inflammation and immune dysfunction and a counter-action to the catabolic state.
Agus MS, Javid PJ, Ryan DP, Jaksic T.2004. Intravenous insulin decreases protein breakdown in infants on extracorporeal membrane oxygenation. J Pediatr Surg39: 839-844.
2.
Bessey PQ, Lowe KA.1993. Early hormonal changes affect the catabolic response to trauma. Ann Surg218: 476-489.
3.
Black CT, Hennessey PJ, Andrassy RJ.1990. Short-term hyperglycemia depresses immunity through nonenzymatic glycosylation of circulating immunoglobulin. J Trauma30: 830-832.
4.
Bochicchio GV, Sung J, Joshi M, Bochicchio K, Johnson SB, Meyer W, Scalea TM.2005. Persistent hyper-glycemia is predictive of outcome in critically ill trauma patients. J Trauma58: 921-924.
5.
Brix-Christensen V, Andersen SK, Andersen R, Mengel A, Dyhr T, Andersen NT, Larsson A, Schmitz O, Orskov H, Tonnesen E.2004. Acute hyperinsulinemia restrains endotoxin-induced systemic inflammatory response: an experimental study in a porcine model. Anesthesiology100: 861-870.
6.
Capes SE, Hunt D, Malmberg K, Gerstein HC.2000. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet355: 773-778.
7.
Capes SE, Hunt D, Malmberg K, Pathak P, Gerstein HC.2001. Stress hyperglycemia and prognosis of stroke in nondiabetic and diabetic patients: a systematic overview. Stroke32: 2426-2432.
8.
Das UN, 2003. Insulin: an endogenous cardioprotector. Curr Opin Crit Care9: 375-383.
9.
Finney SJ, Zekveld C, Elia A, Evans TW.2003. Glucose control and mortality in critically ill patients. JAMA290: 2041-2047.
10.
Furnary AP, Gao G, Grunkemeier GL, Wu Y, Zerr KJ, Bookin SO, Floten HS, Starr A.2003. Continuous insulin infusion reduces mortality in patients with diabetes undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg125: 1007-1021.
11.
Furnary AP, Wu Y, Bookin SO.2004. Effect of hyper-glycemia and continuous intravenous insulin infusions on outcomes of cardiac surgical procedures: the Portland Diabetic Project. Endocr Pract10(Suppl 2), 21-33.
12.
Furnary AP, Zerr KJ, Grunkemeier GL, Starr A.1999. Continuous intravenous insulin infusion reduces the incidence of deep sternal wound infection in diabetic patients after cardiac surgical procedures. Ann Thorac Surg67: 352-360.
13.
Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai, M.2001. Association of hyperglycemia with increased mortality after severe burn injury. J Trauma51: 540-544.
14.
Gore DC, Wolf SE, Sanford AP, Herndon DN, Wolfe RR.2004. Extremity hyperinsulinemia stimulates muscle protein synthesis in severely injured patients. Am J Physiol Endocrinol. Metab286: E529-E534.
15.
Grey NJ, Perdrizet GA.2004. Reduction of nosocomial infections in the surgical intensive-care unit by strict glycemic control. Endocr Pract10(Suppl 2), 46-52.
16.
Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G.2003. Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab88: 1082-1088.
17.
Harris HW, Grunfeld C, Feingold KR, Rapp JH.1990. Human very low density lipoproteins and chylomicrons can protect against endotoxin-induced death in mice. J Clin Invest86: 696-702.
18.
Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, Rapp JH.1993. Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest91: 1028-1034.
19.
Hillier TA, Fryburg DA, Jahn LA, Barrett EJ.1998. Extreme hyperinsulinemia unmasks insulin’s effect to stimulate protein synthesis in the human forearm. Am J Physiol274: E1067-E1074.
20.
Jeremitsky E, Omert LA, Dunham CM, Wilberger J, Rodriguez A.2005. The impact of hyperglycemia on patients with severe brain injury. J Trauma58: 47-50.
21.
Jeschke MG, Klein D, Bolder U, and Einspanier, R. (2004a). Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology145: 4084-4093.
22.
Jeschke MG, Klein D, Herndon DN. (2004b). Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg239: 553-560.
23.
Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG.2004. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg240: 340-349.
24.
Klip A, Tsakiridis T, Marette A, Ortiz PA.1994. Regulation of expression of glucose transporters by glucose: a review of studies in vivo and in cell cultures. FASEB J8: 43-53.
25.
Krinsley JS.2004. Effect of an intensive glucose management protocol on the mortality of critically ill adult patients. Mayo Clin Proc79: 992-1000.
26.
Laird AM, Miller PR, Kilgo PD, Meredith JW, Chang MC.2004. Relationship of early hyper-glycemia to mortality in trauma patients. J Trauma56: 1058-1062.
27.
Langouche L, Vanhorebeek I, Vlasselaers D, Vander Perre S, Wouters PJ, Skogstrand K, Hansen TK, Van den Berghe G.2005. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest115: 2277-2286.
28.
Malmberg K.1997. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus. DIGAMI (Diabetes Mellitus, Insulin Glucose Infusion in Acute Myocardial Infarction) Study Group. Brit Med J314: 1512-1515.
29.
McCowen KC, Malhotra A, Bistrian BR.2001. Stress-induced hyperglycemia. Crit Care Clin17: 107-124.
30.
Mesotten D, Delhanty PJ, Vanderhoydonc F, Hardman KV, Weekers F, Baxter RC, Van den Berghe G.2002. Regulation of insulin-like growth factor binding protein-1 during protracted critical illness. J Clin Endocrinol Metab87: 5516-5523.
31.
Mesotten D, Swinnen JV, Vanderhoydonc F, Wouters PJ, Van den Berghe, G.2004. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab89: 219-226.
32.
Rovlias A, Kotsou S.2000. The influence of hyperglycemia on neurological outcome in patients with severe head injury. Neurosurgery46: 335-342.
33.
Siroen MP, van Leeuwen PA, Nijveldt RJ, Teerlink T, Wouters PJ, Van den BG.2005. Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?Crit Care Med33: 504-510.
34.
Soop M, Duxbury H, Agwunobi AO, Gibson JM, Hopkins SJ, Childs C, Cooper RG, Maycock P, Little RA, Carlson GL.2002. Euglycemic hyperinsulinemia augments the cytokine and endocrine responses to endotoxin in humans. Am J Physiol Endocrinol Metab282: E1276-E1285.
35.
Thorell A, Nygren J, Ljungqvist O.1999. Insulin resistance: a marker of surgical stress. Curr Opin Clin Nutr Metab Care2: 69-78.
36.
Van den Berghe G.2004. How does blood glucose control with insulin save lives in intensive care?J Clin Invest114: 1187-1195.
37.
Van den Berghe G, Schoonheydt K, Becx P, Bruyninckx F, Wouters PJ.2005. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology64: 1348-1353.
38.
Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R.2001. Intensive insulin therapy in critically ill patients. N Engl J Med345: 1359-1367.
39.
Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P.2003. Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med31: 359-366.
40.
Vanhorebeek I, De Vos R, Mesotten D, Wouters PJ, Wolf-Peeters C, Van den Berghe G.2005. Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet365: 53-59.
41.
Weekers F, Giulietti AP, Michalaki M, Coopmans W, Van Herck E, Mathieu C, Van den Berghe G.2003. Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. Endocrinology144: 5329-5338.
Wolfe RR, Herndon DN, Jahoor F, Miyoshi H, Wolfe M.1987. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med317: 403-408.
44.
Yendamuri S, Fulda GJ, Tinkoff GH.2003. Admission hyperglycemia as a prognostic indicator in trauma. J Trauma55: 33-38.
45.
Zerr KJ, Furnary AP, Grunkemeier GL, Bookin S, Kanhere V, Starr A.1997. Glucose control lowers the risk of wound infection in diabetics after open heart operations. Ann Thorac Surg63: 356-361.
46.
Zhang XJ, Chinkes DL, Irtun O, Wolfe RR.2002. Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. Am J Physiol Endocrinol Metab282: E1308-E1315.
